CEO Schreiber Taylor bought 36,500 shares of STTK at $1.21, doubling his stake to 71,002 shares amid -88.7% 52-week decline.
CEO Schreiber Taylor purchased 36,500 shares at $1.21 on 2024-10-07, increasing his holdings by 105.8% from 34,502 to 71,002 shares. The purchase occurred with the stock trading 88.7% below its $11.18 52-week high and down 64.0% over the preceding 30 days. His prior open-market purchase at this company on 2024-06-26 posted a +6.5% 90-day return, suggesting some pattern of entry timing at STTK. However, the company's fundamentals show severe deterioration: it generated only $1.6M in revenue in its latest quarter, reported -$21.6M in net income, and remains unprofitable despite 154.1% annual revenue growth. The extreme valuation pressure—stock at -88.7% from 52-week highs—combined with substantial quarterly losses creates material execution risk that extends beyond typical valuation multiples.
STTK CEO Schreiber Taylor bought 14,400 shares at $3.47; holdings now 34,502 shares (+71.6% increase)
CEO Schreiber Taylor purchased 14,400 shares at $3.47 on 2024-06-26, increasing his position by 71.6% to 34,502 shares total. The transaction occurred at a price that has since declined significantly: the stock currently trades at $3.79 (down 66.1% from the 52-week high of $11.18) and the 90-day trend is down 57.6%. Shattuck Labs remains unprofitable with net income of $-18.5M on quarterly revenue of $1.1M, though the company demonstrated strong annual revenue growth of +154.1%. The CEO's substantial accumulation at depressed price levels during a period of significant stock decline warrants examination of whether this reflects conviction in the business recovery or other strategic considerations, particularly given the company's ongoing losses and steep drawdown from recent highs.
